These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 18573819

  • 1. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
    Miyazaki Y, Iwabuchi K, Kikuchi S, Fukazawa T, Niino M, Hirotani M, Sasaki H, Onoé K.
    Mult Scler; 2008 Sep; 14(8):1044-55. PubMed ID: 18573819
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.
    Krakauer M, Sorensen PS, Khademi M, Olsson T, Sellebjerg F.
    Scand J Immunol; 2006 Aug; 64(2):155-63. PubMed ID: 16867161
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [Abstract] [Full Text] [Related]

  • 6. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
    Mei FJ, Osoegawa M, Ochi H, Minohara M, Nan S, Murai H, Ishizu T, Taniwaki T, Kira J.
    J Neurol Sci; 2006 Jul 15; 246(1-2):71-7. PubMed ID: 16581087
    [Abstract] [Full Text] [Related]

  • 7. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P, Romano MR, Boccardi B, Lombardo F, Moscato G, Mosti S, Baldini C, Nuti S, Meucci G, Rossi B.
    Rev Neurol; 2006 Jul 15; 29(10):893-9. PubMed ID: 10637835
    [Abstract] [Full Text] [Related]

  • 8. Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
    Urshansky N, Mausner-Fainberg K, Auriel E, Regev K, Bornstein NM, Karni A.
    J Neuroimmunol; 2011 Mar 15; 232(1-2):171-8. PubMed ID: 21111488
    [Abstract] [Full Text] [Related]

  • 9. Phenotypic classification of human CD4+ T cell subsets and their differentiation.
    Okada R, Kondo T, Matsuki F, Takata H, Takiguchi M.
    Int Immunol; 2008 Sep 15; 20(9):1189-99. PubMed ID: 18635582
    [Abstract] [Full Text] [Related]

  • 10. Increased frequency of IFN-gamma-producing peripheral CD8+ T cells with memory-phenotype in patients with chronic hepatitis C.
    Murata M, Nabeshima S, Maeda N, Nakashima H, Kashiwagi S, Hayashi J.
    J Med Virol; 2002 Jun 15; 67(2):162-70. PubMed ID: 11992577
    [Abstract] [Full Text] [Related]

  • 11. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K, Reder AT.
    Mult Scler; 2007 May 15; 13(4):459-70. PubMed ID: 17463069
    [Abstract] [Full Text] [Related]

  • 12. Association between peripheral IFN-gamma producing CD8+ T-cells and disability score in relapsing-remitting multiple sclerosis.
    Sepulcre J, Sanchez-Ibarrola A, Moreno C, de Castro P.
    Cytokine; 2005 Oct 21; 32(2):111-6. PubMed ID: 16246570
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative analysis of naïve and memory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics.
    Yakoub-Agha I, Saule P, Depil S, Grutzmacher C, Boulanger F, Magro L, Jouet JP, Dessaint JP, Labalette M.
    Exp Hematol; 2007 Jun 21; 35(6):861-71. PubMed ID: 17533040
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy.
    Becher B, Giacomini PS, Pelletier D, McCrea E, Prat A, Antel JP.
    Ann Neurol; 1999 Feb 21; 45(2):247-50. PubMed ID: 9989628
    [Abstract] [Full Text] [Related]

  • 17. Effect of IFN-beta therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study.
    Namdar A, Nikbin B, Ghabaee M, Bayati A, Izad M.
    J Neuroimmunol; 2010 Jan 25; 218(1-2):120-4. PubMed ID: 19932513
    [Abstract] [Full Text] [Related]

  • 18. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.
    Mehling M, Brinkmann V, Antel J, Bar-Or A, Goebels N, Vedrine C, Kristofic C, Kuhle J, Lindberg RL, Kappos L.
    Neurology; 2008 Oct 14; 71(16):1261-7. PubMed ID: 18852441
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
    Jensen MA, Yanowitch RN, Reder AT, White DM, Arnason BG.
    Mult Scler; 2010 Jan 14; 16(1):30-8. PubMed ID: 20007427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.